In recent weeks, The Cancer Letter has reported on 2022 AACR awards presented to Tony Hunter, John E. Dick, Elaine S. Jaffe, Levi A. Garraway, Karen Lu, and Steven A. Roseberg, as well as this year’s AACR Fellows (The Cancer Letter, March 25, March 25, April 1, 2022).
As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment.
